Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,859 | -54.8% | 8,231 | -43.7% | 0.00% | – |
| Q2 2023 | $99,256 | +180.3% | 14,618 | +106.8% | 0.00% | – |
| Q1 2023 | $35,416 | +96.8% | 7,069 | +447.6% | 0.00% | – |
| Q3 2022 | $18,000 | -21.7% | 1,291 | -15.8% | 0.00% | – |
| Q2 2022 | $23,000 | -89.2% | 1,533 | -91.4% | 0.00% | – |
| Q1 2022 | $212,000 | -54.9% | 17,887 | -38.2% | 0.00% | – |
| Q4 2021 | $470,000 | -60.9% | 28,965 | -31.2% | 0.00% | – |
| Q3 2021 | $1,203,000 | +114.1% | 42,123 | +153.8% | 0.00% | – |
| Q2 2021 | $562,000 | +29.2% | 16,600 | +15.5% | 0.00% | – |
| Q1 2021 | $435,000 | -67.3% | 14,374 | -46.5% | 0.00% | – |
| Q4 2020 | $1,331,000 | +110.6% | 26,885 | +63.7% | 0.00% | – |
| Q3 2020 | $632,000 | -20.1% | 16,424 | -10.3% | 0.00% | – |
| Q2 2020 | $791,000 | +140.4% | 18,308 | +45.4% | 0.00% | – |
| Q1 2020 | $329,000 | -4.1% | 12,588 | +14.6% | 0.00% | – |
| Q4 2019 | $343,000 | -50.6% | 10,982 | -58.8% | 0.00% | – |
| Q3 2019 | $695,000 | +58.7% | 26,672 | +38.9% | 0.00% | – |
| Q2 2019 | $438,000 | +356.2% | 19,203 | +422.2% | 0.00% | – |
| Q1 2019 | $96,000 | +37.1% | 3,677 | +2.1% | 0.00% | – |
| Q4 2018 | $70,000 | – | 3,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 216,916 | $6,191,000 | 3.86% |
| Sofinnova Investments, Inc. | 2,194,278 | $62,625,000 | 3.71% |
| MPM BioImpact LLC | 452,970 | $12,928,000 | 2.00% |
| Soleus Capital Management, L.P. | 265,700 | $7,583,000 | 1.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 452,110 | $12,903,000 | 1.17% |
| ORACLE INVESTMENT MANAGEMENT INC | 315,642 | $9,008,000 | 1.12% |
| First Light Asset Management, LLC | 577,663 | $16,487,000 | 1.09% |
| Lombard Odier Asset Management (Switzerland) SA | 352,839 | $10,070,000 | 0.62% |
| Cormorant Asset Management, LP | 500,000 | $14,270,000 | 0.58% |
| Artal Group S.A. | 400,000 | $11,416,000 | 0.26% |